Description:
The Medline MDS600SQ Hemo Force SQ Sequential DVT Pump is a non-invasive pneumatic compression system engineered to prevent Deep Vein Thrombosis (DVT) in immobile or recovering patients. Operating via specialized microprocessor-controlled airflow, it sequentially inflates multi-chambered leg or foot sleeves to mimic natural walking blood flow and enhance venous return. This system supports critical patient safety workflows across acute care, surgical suites, and medical equipment testing environments. This lot configuration consists of five electrical compression pump units.
Specifications:
-
Manufacturer: Medline Industries
-
Product Type: Sequential Compression Device (SCD) / DVT Pump
-
Model: Hemo Force SQ (MDS600SQ)
-
Compression Profile: Sequential, gradient pressure delivery
-
Cycle Parameters: Intermittent inflation and deflation phases
-
Enclosure Housing: Impact-resistant, lightweight clinical-grade polymer
-
Electrical Requirements: Standard AC Power Input
-
Application Settings: Operating Room, Post-Op Recovery, and Medical Equipment Processing
Features:
-
Sequential Gradient Compression: Inflates compression garments from the ankle upward to effectively push pooled blood toward the heart
-
One-Button Interface Setup: Designed with a simplified, intuitive control layout to reduce clinical setup time and maximize processing efficiency
-
Independent Dual-Leg Operation: Features dual pneumatic quick-connect ports capable of running a single garment or two garments simultaneously
-
Integrated Bed Hanger: Built-in rear brackets fold out easily for secure attachment to hospital bed footboards, saving valuable floor space
-
Comprehensive Safety Array: Equipped with visible and audible alert protocols to instantly notify operators of low pressure, kinked tubing, or power disruption
Need This Product Certified Patient-Ready?
If you require this product to be patient-ready certified, you can request a quote. Inspection, testing, repair, electrical safety testing, and calibration services are available through A Biomedical Service, Inc.







